Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alfardan Group is a prominent Qatari conglomerate with a diverse portfolio spanning automotive, jewelry, real estate, hospitality, and healthcare. In the healthcare sector, the group operates Alfardan Medical with Northwestern Medicine (AMNM), a premium ambulatory care center located in Lusail, Qatar. This facility provides high-quality, patient-focused medical care across various specialties, leveraging a strategic partnership with the U.S.-based Northwestern Medicine. The group's healthcare division focuses on delivering advanced clinical services, including cardiology, orthopedics, and internal medicine, using state-of-the-art medical technology. While not a traditional biotechnology or pharmaceutical development company, Alfardan Group is a significant investor and provider in the regional healthcare infrastructure. The company is family-owned and has been a key driver of economic growth in the Gulf region since its founding in 1954.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alfardan Group.